Emcure Pharmaceuticals (EMCURE) delivery and trend
Research snapshot: 2026-11-06. NSE delivery session: 2026-11-06. These are dated observations, not live quotes.
Open EMCURE interactive chartPrice and 52-week position
NSE closing price: ₹2,212.8 (2026-11-06). Technical-feed price: ₹2,216.2. Sources can have different quote times.
Approximate 52-week daily closing range: ₹1,337.4 to ₹2,244.94. Price is -1.28% from its high and 65.71% above its low. Range estimates are reconstructed from rounded technical-feed distances; they are not intraday extremes.
One-month return: 19.7%. Three-month return: 12.02%. One-year return: 55.35%.
Delivery percentage and recent history
62.33% delivered; delivered quantity is 1.58× its prior 20-session average. Prior average delivery percentage: 53.77%. Latest delivered shares: 1,44,458.
| Session | Delivery percentage |
|---|---|
| 2026-10-26 | 58.65% |
| 2026-10-27 | 58.78% |
| 2026-10-28 | 59.46% |
| 2026-10-29 | 53.02% |
| 2026-10-30 | 59.51% |
| 2026-11-02 | 64.89% |
| 2026-11-03 | 23.55% |
| 2026-11-04 | 36.98% |
| 2026-11-05 | 49.65% |
| 2026-11-06 | 62.33% |
Delivery volume does not identify buyers or prove institutional accumulation.
Trend and matching screens
Above the 50-day average; above the 200-day average. RSI (14): 76.16. Composite screening score: 99 / 100.
- Momentum leaders — Top composite score, in a long-term uptrend, not stretched.
- Minervini trend template — Stage-2 structure: price > 50 > 150 > 200 DMA, 200 DMA rising for a month, ≥30% above the 52W low, within 25% of the high, composite score ≥ 70 as the relative-strength leg.
- Relative strength — Beating the Nifty 50 by 10+ points over 3 months and still rising.
Sources: NSE security-wise delivery bhavcopy and Yahoo Finance daily closing history. Calculation methodology. Check the current chart before relying on an older snapshot.